Resident/Fellow Research Grants
Due to the success of the Medical Student Research Grant program, in 2024 the MRF will introduce resident/fellow research grants as well. The purpose of these 1-year, $10,000 awards is to promote research opportunities to resident/fellows early in their careers by funding clinical or laboratory-based research projects focused on better understanding the prevention, early detection, behaviors that impact melanoma risk, biology and treatment of melanoma, including cutaneous, ocular, mucosal, pediatric, etc. In 2024, in addition to awards focused on any aspect of melanoma research, the MRF is pleased to also offer at least one award focused specifically on ocular melanoma research. Applications for 2024 grants will be accepted until January 31, 2024 at 5pm ET. Decisions will be made and announced by April 1, 2024. Additional information including eligibility requirements and application instructions can be found in the Request for Proposals (RFP).
MRF Breakthrough Consortium (MRFBC) Pilot Translational Award Funded by the Brodman Charitable Fund & Friends
This one-year pilot proposal for $50,000 focuses on clinical/ translational research. As this is a pilot award, preliminary data is not required. The goal of the pilot proposal is to create findings that could then lend themselves to larger, multicenter grant proposals. Both tenured and non-tenured track faculty are encouraged to apply. Applications for 2024 grants will be accepted until February 20th, 2024 at 5pm ET. Additional information including eligibility requirements and application instructions can be found in the 2024 MRFBC Pilot Translational Award Request for Proposals (RFP).
MRF Breakthrough Consortium Young Investigator Team Award to Advance the Field of Translational Immuno-Oncology (MRFBC)
The MRFBC Team Award provides funding of up to $150,000 per year for two years to an investigative team whose research focuses on either improving clinical outcomes for patients with melanoma being treated with immuno‐oncology agents or advancing the scientific understanding of immuno‐oncology and the role of the immune system in melanoma. Teams must involve collaborations from at least two different institutions, one of which must be a MRFBC member institution. Further, the proposed PI and all co-PIs must be junior scientists, all of whom have at least one mentor. Applications for 2024 grants will be accepted until March 1st, 2024 at 5pm ET. Additional information including eligibility requirements and applications instructions can be found in the 2024 Team/ EIA/ CDA Request for Proposals (RFP).
Established Investigator Awards (EIA)
The EIAs provide funding of up to $125,000 per year for two years to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. Applications for 2024 grants will be accepted until March 1st, 2024 at 5pm ET. Additional information including eligibility requirements and applications instructions can be found in the 2024 Team/ EIA/ CDA Request for Proposals (RFP).
Career Development Awards (CDA)
The CDAs provide funding of up to $50,000 per year for two years to junior investigators. Researchers who are beginning a research career focused on melanoma are eligible. This year, in addition to general CDAs, the MRF will offer the MRF Prevention Award in Honor of Teddi Mellencamp/ PREV CDA. Applications for 2024 grants will be accepted until March 1st, 2024 at 5pm ET. Additional information including eligibility requirements and applications instructions can be found in the 2024 Team/ EIA/ CDA Request for Proposals (RFP).
For any additional information or any questions, please email research@melanoma.org.